Eligible development and sales milestone payments to be received.

No definition available.

Name:	LPCN_EligibleDevelopmentAndSalesMilestonePaymentsToBeReceived
Namespace Prefix:	LPCN_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

License fee.

+ References

No definition available.

+ Details

Name:	LPCN_LicenseFee
Namespace Prefix:	LPCN_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Payment received for license fee

+ References

No definition available.

+ Details

Name:	LPCN_PaymentReceivedForLicenseFee
Namespace Prefix:	LPCN_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Payments will be made for license fees.

+ References

No definition available.

+ Details

Name:	LPCN_PaymentsToBeMadeForLicenseFees
Namespace Prefix:	LPCN_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Percentage of royalties reduction based upon product launch.

+ References

No definition available.

+ Details

Name:	LPCN_PercentageOfRoyaltiesReductionBasedUponProductLaunch
Namespace Prefix:	LPCN_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 730
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482916/730-10-50-1

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

+ Details

Name:	us-gaap_RoyaltyExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount the entity has committed to make for future royalty guarantees.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 928
-SubTopic 440
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477866/928-440-50-1

+ Details

Name:	us-gaap_RoyaltyGuaranteesCommitmentsAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(7))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

+ Details

Name:	us-gaap_RoyaltyIncomeNonoperating
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=LPCN_VerityLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=LPCN_GordonSilverLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=us-gaap_RoyaltyAgreementTermsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=LPCN_AbbottProductsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Contractual Agreements (Details Narrative) - USD ($)						3 Months Ended		9 Months Ended
Contractual Agreements (Details Narrative) - USD ($)	Jan. 05, 2026	Dec. 30, 2024	Feb. 01, 2024	Jan. 12, 2024	Mar. 29, 2012	Sep. 30, 2026	Sep. 30, 2025	Sep. 30, 2026	Sep. 30, 2025
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty revenue recognised						$ 190,072	$ 114,574	$ 499,568	$ 331,287
Contract research and development expenses						1,200,000	2,100,000	4,200,000	3,700,000
Verity License Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty revenue recognised						690,000	115,000	1,000,000	331,000
Verity License Agreement [Member] \| Gordon Silver Limited [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
License fee				$ 11,000,000.0
Initial payment				2,500,000
Payment received for license fee	$ 1,000,000.0	$ 2,500,000	$ 5,000,000.0
Eligible development and sales milestone payments to be received				$ 259,000,000.0
Royalty Agreement Terms [Member] \| Abbott Products, Inc. [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalties, commitment amount					$ 1,000,000.0
Percentage of royalties reduction based upon product launch					50.00%
Royalty expense						$ 16,000	$ 10,000	$ 42,000	$ 28,000